Stop overselling GM on yield, warns plant breeding researcher
By Claire Robinson,
GMWatch
| 09. 26. 2023
Photo by Shuken Nakamura on Unsplash
A young researcher studying plant breeding for her PhD at Cornell University has just published a paper warning GMO promoters not to make overhyped claims about supposed yield gains from GM crops. Merritt Khaipho-Burch is the first author on the new publication, called “Genetic modification can improve crop yields — but stop overselling it”.
Khaipho-Burch initially made her case on Twitter last year, comprehensively debunking papers published in Science Magazine reporting massive yield gains from genetic engineering in rice and soybean plants. The click-bait claims made by Science about these papers were lapped up uncritically by the mainstream media, leading Khaipho-Burch to condemn both papers as “misleading” and former Science Magazine reporter Michael Balter to accuse the journal of being “way too credulous” in certain topic areas of science, such as GMO research.
Now Khaipho-Burch and her co-authors have taken the discussion to a higher level, in the form of a peer-reviewed paper in the world’s leading multidisciplinary science journal, Nature, which drives home many points that GMWatch has been making for years...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...